FDA-Cleared AI

FDA-cleared imaging AI is often used as shorthand for product maturity, but clearance alone does not resolve workflow fit, performance quality, or clinical utility. Imaging buyers still need precise language around intended use, regulatory pathway, and postmarket responsibilities.

This section tracks the regulatory side of imaging AI with an emphasis on accuracy in terminology and practical implications for clinical adoption.

What This Section Covers

• Cleared imaging AI products and use categories
• Intended use and regulatory labeling
• Pathway differences and device classification
• Lifecycle oversight and change management
• Why clearance is not the same as proven superiority